117 related articles for article (PubMed ID: 8541104)
1. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours.
Schlimok G; Pantel K; Loibner H; Fackler-Schwalbe I; Riethmüller G
Eur J Cancer; 1995 Oct; 31A(11):1799-803. PubMed ID: 8541104
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
[TBL] [Abstract][Full Text] [Related]
3. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
Diel IJ; Solomayer EF; Bastert G
Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
[TBL] [Abstract][Full Text] [Related]
4. HER2 status of bone marrow micrometastasis and their corresponding primary tumours in a pilot study of 27 cases: a possible tool for anti-HER2 therapy management?
Vincent-Salomon A; Pierga JY; Couturier J; d'Enghien CD; Nos C; Sigal-Zafrani B; Lae M; Fréneaux P; Diéras V; Thiéry JP; Sastre-Garau X
Br J Cancer; 2007 Feb; 96(4):654-9. PubMed ID: 17262082
[TBL] [Abstract][Full Text] [Related]
5. Micrometastatic bone marrow involvement: detection and prognostic significance.
Braun S; Pantel K
Med Oncol; 1999 Sep; 16(3):154-65. PubMed ID: 10523795
[TBL] [Abstract][Full Text] [Related]
6. Immunocytochemical detection of isolated tumour cells in bone marrow of patients with untreated stage C prostatic cancer.
Pantel K; Aignherr C; Köllermann J; Caprano J; Riethmüller G; Köllermann MW
Eur J Cancer; 1995 Sep; 31A(10):1627-32. PubMed ID: 7488413
[TBL] [Abstract][Full Text] [Related]
7. In vitro detection of occult bone marrow metastases in patients with colorectal cancer hepatic metastases.
Cohen AM; Garin-Chesa P; Hanson M; Weyhrauch K; Kemeny N; Fong Y; Paty P; Welt S; Old L
Dis Colon Rectum; 1998 Sep; 41(9):1112-5. PubMed ID: 9749494
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients.
Braun S; Kentenich C; Janni W; Hepp F; de Waal J; Willgeroth F; Sommer H; Pantel K
J Clin Oncol; 2000 Jan; 18(1):80-6. PubMed ID: 10623696
[TBL] [Abstract][Full Text] [Related]
10. Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy.
Becker S; Becker-Pergola G; Wallwiener D; Solomayer EF; Fehm T
Breast Cancer Res Treat; 2006 May; 97(1):91-6. PubMed ID: 16319975
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow micrometastases and adjuvant treatment of breast cancer.
Yu JJ; Brennan M; Christos P; Osborne MP; Hoda S; Simmons RM
Breast J; 2004; 10(3):181-5. PubMed ID: 15125741
[TBL] [Abstract][Full Text] [Related]
12. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical monitoring of micrometastatic disease: reduction of prostate cancer cells in bone marrow by androgen deprivation.
Pantel K; Enzmann T; Köllermann J; Caprano J; Riethmüller G; Köllermann MW
Int J Cancer; 1997 May; 71(4):521-5. PubMed ID: 9178803
[TBL] [Abstract][Full Text] [Related]
14. Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: results at 4 years.
Slade MJ; Singh A; Smith BM; Tripuraneni G; Hall E; Peckitt C; Fox S; Graham H; Lüchtenborg M; Sinnett HD; Cross NC; Coombes RC
Int J Cancer; 2005 Mar; 114(1):94-100. PubMed ID: 15523696
[TBL] [Abstract][Full Text] [Related]
15. [Immunocytochemical detection of cytokeratin positive cells in human bone marrow of gastric and colorectal cancer patients].
Leinung S; Schönfelder A; Schönfelder M
Zentralbl Chir; 1998; 123(5):520-4. PubMed ID: 22462221
[TBL] [Abstract][Full Text] [Related]
16. Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance.
Schlimok G; Funke I; Pantel K; Strobel F; Lindemann F; Witte J; Riethmüller G
Eur J Cancer; 1991; 27(11):1461-5. PubMed ID: 1720636
[TBL] [Abstract][Full Text] [Related]
17. Immunocytochemical detection of bone marrow micrometastases in colorectal carcinoma patients, using a monoclonal antibody to villin.
Rouzier R; Bourstyn E; Grozier F; Berger A; Louvard D; Robine S
Cytometry; 2001 Oct; 46(5):281-9. PubMed ID: 11746103
[TBL] [Abstract][Full Text] [Related]
18. Implications of occult metastatic cells for systemic cancer treatment in patients with breast or gastrointestinal cancer.
Braun S; Rosenberg R; Thorban S; Harbeck N
Semin Surg Oncol; 2001 Jun; 20(4):334-46. PubMed ID: 11747276
[TBL] [Abstract][Full Text] [Related]
19. Disseminated tumor cells in bone marrow of patients with transitional cell carcinoma: immunocytochemical detection and correlation with established prognostic indicators.
Hofmann T; Riesenberg R; Buchner A; Zimmermann W; Hofstetter A; Oberneder R
J Urol; 2003 Apr; 169(4):1303-7. PubMed ID: 12629348
[TBL] [Abstract][Full Text] [Related]
20. Trastuzumab administration can effectively target chemotherapy-resistant cytokeratin-19 messenger RNA-positive tumor cells in the peripheral blood and bone marrow of patients with breast cancer.
Bozionellou V; Mavroudis D; Perraki M; Papadopoulos S; Apostolaki S; Stathopoulos E; Stathopoulou A; Lianidou E; Georgoulias V
Clin Cancer Res; 2004 Dec; 10(24):8185-94. PubMed ID: 15623593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
